[
  {
    "date": "2023-12-30",
    "symbol": "SLNO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "SOLENO THERAPEUTICS INC",
    "entitycentralindexkey": 1484565,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36593",
    "entitytaxidentificationnumber": "77-0523891",
    "entityaddressaddressline1": "203 Redwood Shores Parkway",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresscityortown": "Redwood City",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94065,
    "cityareacode": 650,
    "localphonenumber": "213-8444",
    "entityincorporationstatecountrycode": "DE",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Marcum LLP",
    "auditorlocation": "San Francisco, CA",
    "auditorfirmid": 688,
    "security12btitle": "Common Stock, $0.001 par value",
    "tradingsymbol": "SLNO",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 169681000,
    "prepaidexpenseandotherassetscurrent": 1677000,
    "assetscurrent": 171358000,
    "propertyplantandequipmentnet": 12000,
    "operatingleaserightofuseasset": 407000,
    "intangibleassetsnetexcludinggoodwill": 8749000,
    "otherassetsnoncurrent": 165000,
    "assets": 180691000,
    "accountspayablecurrent": 3149000,
    "employeerelatedliabilitiescurrent": 3135000,
    "accruedclinicaltrialcostscurrent": 3393000,
    "operatingleaseliabilitycurrent": 273000,
    "otherliabilitiescurrent": 1555000,
    "liabilitiescurrent": 11505000,
    "assetacquisitioncontingentconsiderationliabilitynoncurrent": 11549000,
    "operatingleaseliabilitynoncurrent": 130000,
    "liabilities": 23184000,
    "commonstockvalue": 32000,
    "additionalpaidincapitalcommonstock": 433885000,
    "retainedearningsaccumulateddeficit": -276410000,
    "stockholdersequity": 157507000,
    "liabilitiesandstockholdersequity": 180691000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 31678159,
    "commonstocksharesoutstanding": 31678159,
    "researchanddevelopmentexpense": 25189000,
    "generalandadministrativeexpense": 13481000,
    "assetacquisitioncontingentconsiderationchangeinfairvalue": 2714000,
    "operatingexpenses": 41384000,
    "operatingincomeloss": -41384000,
    "fairvalueadjustmentofwarrants": 182000,
    "othernonoperatingincomeexpense": 2578000,
    "nonoperatingincomeexpense": 2396000,
    "netincomeloss": -38988000,
    "earningspersharebasic": -2.36,
    "earningspersharediluted": -2.36,
    "weightedaveragenumberofsharesoutstandingbasic": 16492132,
    "weightedaveragenumberofdilutedsharesoutstanding": 16492132,
    "sharesoutstanding": 31678159,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5809000,
    "issuanceofrestrictedstockunitsvalueunderequityincentiveplan": 136000,
    "issuanceofrestrictedstockunitssharesunderequityincentiveplan": 423248,
    "sharespaidfortaxwithholdingforsharebasedcompensation": -128,
    "stockissuedduringperiodvaluenewissues": 6000,
    "stockissuedduringperiodsharesnewissues": 7047397,
    "exerciseofcommonstockwarrants": 17000,
    "classofwarrantorrightexercised": 15961267,
    "stockissuedduringperiodvaluestockoptionsexercised": -1000,
    "stockissuedduringperiodsharesstockoptionsexercised": -86993,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 8449000,
    "profitloss": -38988000,
    "depreciationandamortization": 1958000,
    "noncashleaseexpense": 321000,
    "sharebasedcompensation": 5945000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 837000,
    "increasedecreaseinaccountspayable": 1372000,
    "increasedecreaseinemployeerelatedliabilities": 1460000,
    "increasedecreaseinaccruedclinicaltrialsitecosts": 171000,
    "increasedecreaseinoperatingleaseliabilities": -309000,
    "increasedecreaseinotheroperatingliabilities": 1071000,
    "netcashprovidedbyusedinoperatingactivities": -24940000,
    "proceedsfromsaleofcommonstockcommonstockwarrantsandprefundedstockwarrantsnetofissuancecosts": 137857000,
    "proceedsfromexerciseofcommonstockwarrantsandprefundedstockwarrantsnetofcosts": 41815000,
    "proceedsfromstockoptionsexercised": 347000,
    "netcashprovidedbyusedinfinancingactivities": 180019000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 155079000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 169681000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 597000,
    "noncashorpartnoncashacquisitionnoncashfinancialorequityinstrumentconsiderationwarrantsexercised": 183000,
    "proceedsfromissuanceorsaleofequity": 129000000,
    "proceedsfromissuanceofcommonstock": 7400000,
    "contingentreceiptuponexeriseofwarrantsandfutureperformanceofcompany": 16900000,
    "proceedsfromwarrantexercises": 15000000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibleassetsotherthangoodwill": 22000000,
    "finitelivedintangibleassetusefullife": "P11Y",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2023-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "milestonespayment": 100000000,
    "percentageofprobabilityofachievingmilestone": 0.88,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 11549000,
    "classofwarrantorrightoutstanding": 12452,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 419000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://fasb.org/us-gaap/2023#FairValueAdjustmentOfWarrants",
    "exerciseofwarrantsshares": -21789,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityexercise": -183000,
    "expirationofwarrants": -12452,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityexpiration": -237000,
    "propertyplantandequipmentgross": 72000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 89000,
    "depreciation": 14000,
    "adjustmentforamortization": 1900000,
    "finitelivedintangibleassetsgross": 22003000,
    "finitelivedintangibleassetsaccumulatedamortization": 13254000,
    "finitelivedintangibleassetsnet": 8749000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1944000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 973000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 365.25,
    "classofwarrantorrightexercisepricedescription": "The 2018 PIPE Warrants were issued on December 19, 2018 in the 2018 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2018 PIPE Offering, and prior to their expiration on December 21, 2023, entitled the holders to purchase 34,241 shares of the Company’s common stock at an exercise price equal to $30.00 per share, subject to adjustments.",
    "lesseeoperatingleaseextensionexpirationmonthandyear": "2025-05",
    "lesseeoperatingleasedescription": "began in June 2021 and expired in May 2023",
    "lesseeoperatingleasetermofcontract": "P24M",
    "lesseeoperatingleasecommencementmonthandyear": "2021-06",
    "lesseeoperatingleasemonthandyearofexpiration": "2023-05",
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent",
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent",
    "operatingleaserightofuseassetincrease": 600000,
    "increaseinoperatingleaseliability": 600000,
    "operatingleaseweightedaverageremainingleaseterm1": "P17M",
    "operatingleaseweightedaveragediscountratepercent": 0.0825,
    "operatingleasecost": 312000,
    "shorttermleasecost": 44000,
    "operatingleasecostandsubleaseincome": 356000,
    "operatingleasepayments": 341000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 287000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 143000,
    "lesseeoperatingleaseliabilitypaymentsdue": 430000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 27000,
    "operatingleaseliability": 403000,
    "stockandwarrantsissuedduringperiodvaluepreferredstockandwarrants": 10000000,
    "classofwarrantorrightwarrantterm": "P10Y",
    "classofwarrantorrightwarrantsexpirationmonthandyear": "2024-11",
    "ownershipinterestpercentageofvotingrightsofstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1465,
    "allocatedsharebasedcompensationexpense": 5900000,
    "employeeservicesharebasedcompensationtaxbenefitfromcompensationexpense": 1900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1821784,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.04,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 420710,
    "stockissuedduringperiodsharessharebasedcompensation": 414710,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 12000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y9M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2369665,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 48700,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 797988,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2346707,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.18,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 67.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 18.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 11.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y8M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 70834000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableaggregateintrinsicvalue": 20320000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 70834000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 15534,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 423248,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 996,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 43.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 6.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 5.25,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -39180000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 192000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -38988000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -8187000,
    "incometaxreconciliationstateandlocalincometaxes": -505000,
    "incometaxreconciliationforeignincometaxratedifferential": 6000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 8934000,
    "incometaxreconciliationtaxcreditsresearch": 1631000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": -600000,
    "incometaxreconciliationchangeinfairvalueofwarrants": 38000,
    "incometaxreconciliationchangeinfairvalueofcontingentconsideration": 570000,
    "incometaxreconciliationsectiononesixtytwolimitation": 589000,
    "incometaxreconciliationchangeinnetoperatingloss": -39000,
    "incometaxreconciliationchangeinstaterates": 653000,
    "incometaxreconciliationotherreconcilingitems": 94000,
    "deferredtaxassetsoperatinglosscarryforwards": 51481000,
    "deferredtaxassetstaxcreditcarryforwards": 6352000,
    "deferredtaxassetscapitalizedresearchanddevelopment": 6778000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 655000,
    "deferredtaxassetspropertyplantandequipment": 29000,
    "deferredtaxassetscapitallosscarryforwards": 432000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2013000,
    "deferredtaxassetsleaseliability": 85000,
    "deferredtaxassetstaxcreditcarryforwardsother": 54000,
    "deferredtaxassetsgross": 67879000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 1837000,
    "deferredtaxliabilitiesrightofuseassets": 86000,
    "deferredincometaxliabilities": 1923000,
    "deferredtaxassetsnet": 65956000,
    "deferredtaxassetsvaluationallowance": 65956000,
    "valuationallowancedeferredtaxassetchangeinamount": 8900000,
    "operatinglosscarryforwards": 206700000,
    "taxcreditcarryforwardamount": 6400000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpensesamortizationperiod": "P5Y",
    "operatinglosscarryforwardscarriedforwardindefinitely": 93100000,
    "unrecognizedassetsandliabilitiesrelatedtouncertaintaxpositions": 2900000,
    "unrecognizedtaxbenefitsoffsetbyvaluationallowance": 2900000,
    "unrecognizedtaxbenefits": 2938000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1002000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6804
  },
  {
    "date": "2022-12-30",
    "symbol": "SLNO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "SOLENO THERAPEUTICS INC",
    "entitycentralindexkey": 1484565,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36593",
    "entitytaxidentificationnumber": "77-0523891",
    "entityaddressaddressline1": "203 Redwood Shores Parkway",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresscityortown": "Redwood City",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94065,
    "cityareacode": 650,
    "localphonenumber": "213-8444",
    "entityincorporationstatecountrycode": "Delaware",
    "auditorname": "Marcum LLP",
    "auditorlocation": "San Francisco, CA",
    "auditorfirmid": 688,
    "security12btitle": "Common Stock, $0.001 par value",
    "tradingsymbol": "SLNO",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 14602000,
    "prepaidexpenseandotherassetscurrent": 1045000,
    "assetscurrent": 15647000,
    "propertyplantandequipmentnet": 26000,
    "operatingleaserightofuseasset": 131000,
    "intangibleassetsnetexcludinggoodwill": 10693000,
    "assets": 26497000,
    "accountspayablecurrent": 1777000,
    "employeerelatedliabilitiescurrent": 1675000,
    "accruedclinicaltrialcostscurrent": 3222000,
    "operatingleaseliabilitycurrent": 155000,
    "otherliabilitiescurrent": 484000,
    "liabilitiescurrent": 7313000,
    "derivativeliabilitiesnoncurrent": 1000,
    "assetacquisitioncontingentconsiderationliabilitynoncurrent": 8835000,
    "liabilities": 16149000,
    "commonstockvalue": 8000,
    "additionalpaidincapitalcommonstock": 247762000,
    "retainedearningsaccumulateddeficit": -237422000,
    "stockholdersequity": -237422000,
    "liabilitiesandstockholdersequity": 26497000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": 3729,
    "researchanddevelopmentexpense": 15265000,
    "generalandadministrativeexpense": 9844000,
    "assetacquisitioncontingentconsiderationchangeinfairvalue": -712000,
    "operatingexpenses": 24397000,
    "operatingincomeloss": -24397000,
    "fairvalueadjustmentofwarrants": -30000,
    "othernonoperatingincomeexpense": 300000,
    "nonoperatingincomeexpense": 330000,
    "netincomeloss": -24067000,
    "earningspersharebasic": -2.87,
    "earningspersharediluted": -2.87,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2530000,
    "issuanceofrestrictedstockunitssharesunderequityincentiveplan": 18650,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 16000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": -3683,
    "stockissuedduringperiodvaluenewissues": 342000,
    "stockissuedduringperiodsharesnewissues": 104773,
    "classofwarrantorrightexercised": 48688,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 10000,
    "profitloss": -24067000,
    "depreciationandamortization": 1964000,
    "noncashleaseexpense": 290000,
    "sharebasedcompensation": 2530000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -113000,
    "increasedecreaseinaccountspayable": -1477000,
    "increasedecreaseinemployeerelatedliabilities": 947000,
    "increasedecreaseinaccruedclinicaltrialsitecosts": -198000,
    "increasedecreaseinoperatingleaseliabilities": -302000,
    "increasedecreaseinotheroperatingliabilities": 161000,
    "netcashprovidedbyusedinoperatingactivities": -20781000,
    "paymentstoacquirepropertyplantandequipment": 13000,
    "netcashprovidedbyusedininvestingactivities": -13000,
    "proceedsfromsaleofcommonstockandcommonstockwarrantsnetofcosts": 15152000,
    "paymentsofstockissuancecosts": 1044000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 16000,
    "netcashprovidedbyusedinfinancingactivities": 14092000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -6702000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 14602000,
    "proceedsfromissuanceofcommonstock": 300000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "five years",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibleassetsotherthangoodwill": 22000000,
    "finitelivedintangibleassetusefullife": "11 years",
    "timedepositsatorabovefdicinsurancelimit": 1000000,
    "liabilitiesfairvaluedisclosure": 8836000,
    "percentageofprobabilityofachievingmilestone": 0.72,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 8835000,
    "classofwarrantorrightoutstanding": 1100,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -30000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants",
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasischangeinliabilityduetoestimatedfuturerevenuemilestones": -712000,
    "propertyplantandequipmentgross": 101000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 75000,
    "depreciation": 20000,
    "adjustmentforamortization": 1900000,
    "finitelivedintangibleassetsgross": 22003000,
    "finitelivedintangibleassetsaccumulatedamortization": 11310000,
    "finitelivedintangibleassetsnet": 10693000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1944000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 2917000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 535.5,
    "classofwarrantorrightexercisepricedescription": "The 2018 PIPE Warrants were issued on December 19, 2018 in the 2018 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2018 PIPE Offering, and entitle the holders to purchase 34,231 shares of the Company’s common stock at an exercise price equal to $30.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2018 PIPE Warrants and terminating on December 21, 2023.",
    "warrantsandrightsoutstanding": 1000,
    "warrantsandrightsoutstandingmeasurementinput": 0.047400000000000005,
    "warrantsandrightsoutstandingterm": 1,
    "lesseeoperatingleasedescription": "In July 2019, the Company executed a non-cancellable lease agreement for 6,368 square feet of new space in Redwood City, California, which began in September 2019 and expired in May 2021. In April 2021, the Company ",
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityCurrent",
    "financeleaseweightedaverageremainingleaseterm1": 0.4,
    "operatingleaseweightedaverageremainingleaseterm1": 0.4,
    "operatingleasecost": 324000,
    "shorttermleasecost": 29000,
    "operatingleasecostandsubleaseincome": 353000,
    "operatingleasepayments": 354000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 159000,
    "lesseeoperatingleaseliabilitypaymentsdue": 159000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4000,
    "operatingleaseliability": 155000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 57.75,
    "classofwarrantorrightwarrantterm": "10 years",
    "classofwarrantorrightwarrantsexpirationmonthandyear": "November 2024",
    "ownershipinterestpercentageofvotingrightsofstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1864,
    "allocatedsharebasedcompensationexpense": 1838000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 283919,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.62,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 3200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 8965,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.031000000000000003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9500000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 686574,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 5674,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 357573,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 663616,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 28.83,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 19.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 39.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 28.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 19068,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 18646,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 301,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 32.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 57.85,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -24173000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 106000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -24067000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5055000,
    "incometaxreconciliationstateandlocalincometaxes": -527000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 5702000,
    "incometaxreconciliationtaxcreditsresearch": 652000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": -734000,
    "incometaxreconciliationchangeinfairvalueofwarrants": -6000,
    "incometaxreconciliationchangeinfairvalueofcontingentconsideration": -150000,
    "incometaxreconciliationchangeinnetoperatingloss": -739000,
    "incometaxreconciliationchangeincapitallosses": 405000,
    "incometaxreconciliationchangeinstaterates": 375000,
    "incometaxreconciliationotherreconcilingitems": -97000,
    "deferredtaxassetsoperatinglosscarryforwards": 49024000,
    "deferredtaxassetstaxcreditcarryforwards": 4146000,
    "deferredtaxassetscapitalizedresearchanddevelopment": 2828000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 547000,
    "deferredtaxassetspropertyplantandequipment": 44000,
    "deferredtaxassetscapitallosscarryforwards": 555000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2682000,
    "deferredtaxassetsleaseliability": 42000,
    "deferredtaxassetstaxcreditcarryforwardsother": 72000,
    "deferredtaxassetsgross": 59940000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 2888000,
    "deferredtaxliabilitiesrightofuseassets": 35000,
    "deferredincometaxliabilities": 2923000,
    "deferredtaxassetsnet": 57017000,
    "deferredtaxassetsvaluationallowance": 57017000,
    "valuationallowancedeferredtaxassetchangeinamount": 5700000,
    "operatinglosscarryforwards": 500000,
    "taxcreditcarryforwardamount": 2500000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpensesamortizationperiod": "fifteen years",
    "operatinglosscarryforwardscarriedforwardindefinitely": 90100000,
    "unrecognizedassetsandliabilitiesrelatedtouncertaintaxpositions": 1900000,
    "unrecognizedtaxbenefitsoffsetbyvaluationallowance": 1900000,
    "unrecognizedtaxbenefits": 1936000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 379000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2021-12-30",
    "symbol": "SLNO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "SOLENO THERAPEUTICS INC",
    "entitycentralindexkey": 1484565,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36593",
    "entitytaxidentificationnumber": "77-0523891",
    "entityaddressaddressline1": "203 Redwood Shores Parkway",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresscityortown": "Redwood City",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94065,
    "cityareacode": 650,
    "localphonenumber": "213-8444",
    "entityincorporationstatecountrycode": "Delaware",
    "auditorname": "Marcum LLP",
    "auditorlocation": "San Francisco, CA",
    "auditorfirmid": 688,
    "security12btitle": "Common Stock, $0.001 par value",
    "tradingsymbol": "SLNO",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 21304000,
    "prepaidexpenseandotherassetscurrent": 1118000,
    "assetscurrent": 22422000,
    "propertyplantandequipmentnet": 33000,
    "operatingleaserightofuseasset": 421000,
    "intangibleassetsnetexcludinggoodwill": 12637000,
    "otherassetsnoncurrent": 40000,
    "assets": 35553000,
    "accountspayablecurrent": 3254000,
    "employeerelatedliabilitiescurrent": 728000,
    "accruedclinicaltrialcostscurrent": 3420000,
    "operatingleaseliabilitycurrent": 282000,
    "otherliabilitiescurrent": 323000,
    "liabilitiescurrent": 8007000,
    "derivativeliabilitiesnoncurrent": 31000,
    "assetacquisitioncontingentconsiderationliabilitynoncurrent": 9547000,
    "operatingleaseliabilitynoncurrent": 175000,
    "liabilities": 17760000,
    "commonstockvalue": 80000,
    "additionalpaidincapitalcommonstock": 231068000,
    "retainedearningsaccumulateddeficit": -213355000,
    "stockholdersequity": -213355000,
    "liabilitiesandstockholdersequity": 35553000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": 55936,
    "researchanddevelopmentexpense": 21453000,
    "generalandadministrativeexpense": 10806000,
    "assetacquisitioncontingentconsiderationchangeinfairvalue": -731000,
    "operatingexpenses": 31528000,
    "operatingincomeloss": -31528000,
    "fairvalueadjustmentofwarrants": -500000,
    "othernonoperatingincomeexpense": 110000,
    "nonoperatingincomeexpense": 618000,
    "netincomeloss": -30910000,
    "earningspersharebasicanddiluted": -0.39,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3276000,
    "issuanceofrestrictedstockunitssharesunderequityincentiveplan": 307690,
    "adjustmentstoadditionalpaidincapitalincometaxdeficiencyfromsharebasedcompensation": -120000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": -59072,
    "profitloss": -30910000,
    "depreciationandamortization": 1963000,
    "noncashleaseexpense": 288000,
    "sharebasedcompensation": 3276000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 139000,
    "increasedecreaseinaccountspayable": -235000,
    "increasedecreaseinemployeerelatedliabilities": -277000,
    "increasedecreaseinaccruedclinicaltrialsitecosts": -369000,
    "increasedecreaseinoperatingleaseliabilities": -263000,
    "increasedecreaseinotheroperatingliabilities": 135000,
    "netcashprovidedbyusedinoperatingactivities": -27770000,
    "paymentstoacquirepropertyplantandequipment": 22000,
    "netcashprovidedbyusedininvestingactivities": -22000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 120000,
    "financeleaseprincipalpayments": 8000,
    "netcashprovidedbyusedinfinancingactivities": -128000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -27920000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 21304000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 581000,
    "concentrationriskcreditrisknumberofbanks": 1,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "five years",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibleassetsotherthangoodwill": 22000000,
    "finitelivedintangibleassetusefullife": 11,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "liabilitiesfairvaluedisclosure": 9578000,
    "assetacquisitioncontingentconsiderationarrangementsearnoutpayment": 21200000,
    "percentageofprobabilityofachievingmilestone": 0.72,
    "commercialmilestonesinapplicablerevenueyearthree": 100000000,
    "commercialmilestonesinapplicablerevenueyearfour": 200000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 9547000,
    "classofwarrantorrightoutstanding": 16500,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -508000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasischangeinliabilityduetoestimatedfuturerevenuemilestones": 3249000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasischangeinliabilityduetoassignmentofrights": -3980000,
    "propertyplantandequipmentgross": 101000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 68000,
    "depreciation": 19000,
    "adjustmentforamortization": 1900000,
    "finitelivedintangibleassetsgross": 22003000,
    "finitelivedintangibleassetsaccumulatedamortization": 9366000,
    "finitelivedintangibleassetsnet": 12637000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1944000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 4861000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 118083,
    "tenderofferexpirationdate": "December 15, 2020",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 35.7,
    "classofwarrantorrightexercisepricedescription": "The 2018 PIPE Warrants were issued on December 19, 2018 in the 2018 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2018 PIPE Offering, and entitle the holders to purchase 513,617 shares of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2018 PIPE Warrants and terminating on December 21, 2023.",
    "warrantsandrightsoutstanding": 31000,
    "warrantsandrightsoutstandingmeasurementinput": 0.0072,
    "warrantsandrightsoutstandingterm": "P2Y",
    "lesseeoperatingleasedescription": "In July 2019, the Company executed a non-cancellable lease agreement for 6,368 square feet of new space in Redwood City, California, which began in September 2019 and expired in May 2021. In April 2021, the Company executed a non-cancellable operating lease agreement for the same 6,368 square feet of space, which began in June 2021 and expires in May 2023.",
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent",
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent",
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent",
    "financeleaseweightedaverageremainingleaseterm1": "P1Y4M24D",
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y4M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.09,
    "operatingleasecost": 316000,
    "variableleasecost": 6000,
    "shorttermleasecost": 24000,
    "operatingleasecostandsubleaseincome": 346000,
    "financeleaserightofuseassetamortization": 4000,
    "financeleasecost": 4000,
    "operatingleasepayments": 277000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 315000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 179000,
    "lesseeoperatingleaseliabilitypaymentsdue": 494000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 37000,
    "operatingleaseliability": 457000,
    "preferredstocksharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.85,
    "classofwarrantorrightwarrantterm": 10,
    "classofwarrantorrightwarrantsexpirationmonthandyear": "November 2024",
    "ownershipinterestpercentageofvotingrightsofstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 27967,
    "allocatedsharebasedcompensationexpense": 2542000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.7,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 1200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 177941,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 2.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.014,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 1.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 175000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.09,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 4.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y10M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 435750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 323191,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.31,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -30453000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -457000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -30910000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -6501000,
    "incometaxreconciliationstateandlocalincometaxes": -2342000,
    "incometaxreconciliationforeignincometaxratedifferential": 12000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 8711000,
    "incometaxreconciliationtaxcreditsresearch": 364000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 52000,
    "incometaxreconciliationchangeinfairvalueofwarrants": -107000,
    "incometaxreconciliationchangeinfairvalueofcontingentconsideration": -153000,
    "incometaxreconciliationchangeinnetoperatingloss": -712000,
    "incometaxreconciliationotherreconcilingitems": -20000,
    "deferredtaxassetsoperatinglosscarryforwards": 48542000,
    "deferredtaxassetstaxcreditcarryforwards": 3312000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 573000,
    "deferredtaxassetspropertyplantandequipment": 59000,
    "deferredtaxassetscapitallosscarryforwards": 1115000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1133000,
    "deferredtaxassetsleaseliability": 133000,
    "deferredtaxassetstaxcreditcarryforwardsother": 102000,
    "deferredtaxassetsgross": 54969000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 3536000,
    "deferredtaxliabilitiesrightofuseassets": 118000,
    "deferredincometaxliabilities": 3654000,
    "deferredtaxassetsnet": 51315000,
    "deferredtaxassetsvaluationallowance": 51315000,
    "valuationallowancedeferredtaxassetchangeinamount": 8700000,
    "operatinglosscarryforwards": 500000,
    "taxcreditcarryforwardamount": 1200000,
    "operatinglosscarryforwardscarriedforwardindefinitely": 82900000,
    "unrecognizedassetsandliabilitiesrelatedtouncertaintaxpositions": 1600000,
    "unrecognizedtaxbenefitsoffsetbyvaluationallowance": 1600000,
    "unrecognizedtaxbenefits": 1557000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 234000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2020-12-30",
    "symbol": "SLNO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "SOLENO THERAPEUTICS INC",
    "entitycentralindexkey": 1484565,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36593",
    "entitytaxidentificationnumber": "77-0523891",
    "entityaddressaddressline1": "203 Redwood Shores Parkway",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresscityortown": "Redwood City",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94065,
    "cityareacode": 650,
    "localphonenumber": "213-8444",
    "entityincorporationstatecountrycode": "DE",
    "security12btitle": "Common Stock, $0.001 par value",
    "tradingsymbol": "SLNO",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 49224000,
    "prepaidexpenseandotherassetscurrent": 1019000,
    "assetscurrent": 50243000,
    "propertyplantandequipmentnet": 19000,
    "operatingleaserightofuseasset": 124000,
    "financeleaserightofuseasset": 15000,
    "intangibleassetsnetexcludinggoodwill": 14581000,
    "assets": 64982000,
    "accountspayablecurrent": 3489000,
    "employeerelatedliabilitiescurrent": 1005000,
    "accruedclinicaltrialcostscurrent": 3789000,
    "operatingleaseliabilitycurrent": 139000,
    "otherliabilitiescurrent": 196000,
    "liabilitiescurrent": 8618000,
    "derivativeliabilitiesnoncurrent": 539000,
    "assetacquisitioncontingentconsiderationliabilitynoncurrent": 10278000,
    "liabilities": 19435000,
    "commonstockvalue": 80000,
    "additionalpaidincapitalcommonstock": 227912000,
    "retainedearningsaccumulateddeficit": -182445000,
    "stockholdersequity": -182445000,
    "liabilitiesandstockholdersequity": 64982000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 79615692,
    "commonstocksharesoutstanding": 55936,
    "researchanddevelopmentexpense": 23191000,
    "generalandadministrativeexpense": 8758000,
    "assetacquisitioncontingentconsiderationchangeinfairvalue": 4340000,
    "operatingexpenses": 36289000,
    "operatingincomeloss": -36289000,
    "fairvalueadjustmentofwarrants": -800000,
    "othernonoperatingincomeexpense": 13000,
    "nonoperatingincomeexpense": 11650000,
    "netincomeloss": -24639000,
    "earningspersharebasicanddiluted": -0.39,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 62620227,
    "sharesoutstanding": 79615692,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1500000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 17000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 109154,
    "stockissuedduringperiodvaluenewissues": 53722000,
    "stockissuedduringperiodsharesnewissues": 34848484,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 3778000,
    "profitloss": -24639000,
    "depreciationandamortization": 1954000,
    "noncashleaseexpense": 283000,
    "sharebasedcompensation": 1500000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 549000,
    "increasedecreaseinaccountspayable": 1494000,
    "increasedecreaseinemployeerelatedliabilities": 722000,
    "increasedecreaseinaccruedclinicaltrialsitecosts": 1790000,
    "increasedecreaseinoperatingleaseliabilities": -305000,
    "increasedecreaseinotheroperatingliabilities": -177000,
    "netcashprovidedbyusedinoperatingactivities": -25224000,
    "paymentstoacquirepropertyplantandequipment": 7000,
    "netcashprovidedbyusedininvestingactivities": -7000,
    "proceedsfromsaleofcommonstockandcommonstockwarrantsnetofcosts": 53722000,
    "proceedsfromstockoptionsexercised": 17000,
    "financeleaseprincipalpayments": 17000,
    "netcashprovidedbyusedinfinancingactivities": 53722000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 28491000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 49224000,
    "capitalexpendituresincurredbutnotyetpaid": 1000,
    "concentrationriskcreditrisknumberofbanks": 1,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibleassetsotherthangoodwill": 22000000,
    "finitelivedintangibleassetusefullife": "P11Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateearlyadoption": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "liabilitiesfairvaluedisclosure": 10817000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 10278000,
    "classofwarrantorrightoutstanding": 16500,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 4340000,
    "expirationofwarrants": -6024425,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityexpiration": -10822000,
    "propertyplantandequipmentgross": 54000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 35000,
    "depreciation": 11000,
    "adjustmentforamortization": 1900000,
    "finitelivedintangibleassetsgross": 22003000,
    "finitelivedintangibleassetsaccumulatedamortization": 7422000,
    "finitelivedintangibleassetsnet": 14581000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1944000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1944000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 4861000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 118083,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 35.7,
    "classofwarrantorrightwarrantterm": "P10Y",
    "warrantsexercised": 4800,
    "tenderofferexpirationdate": "2020-03-05",
    "classofwarrantorrightliquidateddamagesamountpercentofvolumeweightedaverageprice": 0.01,
    "classofwarrantorrightexercisepricedescription": "The 2018 PIPE Warrants were issued on December 19, 2018 in the 2018 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2018 PIPE Offering, and entitle the holders to purchase 513,617 shares of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2018 PIPE Warrants and terminating on December 21, 2023.",
    "warrantsandrightsoutstanding": 500000,
    "warrantsandrightsoutstandingmeasurementinput": 0.0017,
    "warrantsandrightsoutstandingterm": "P3Y",
    "lesseeoperatingleasedescription": "the Company executed a non-cancellable lease agreement for 6,368 square feet of new space in Redwood City, California, which began in September 2019 and expires in May 2021.",
    "financeleaseliabilitycurrent": 8000,
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesCurrent",
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesNoncurrent",
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesNoncurrent",
    "financeleaseweightedaverageremainingleaseterm1": "P4M24D",
    "financeleaseweightedaveragediscountratepercent": 0.1,
    "operatingleaseweightedaverageremainingleaseterm1": "P4M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.1,
    "operatingleasecost": 305000,
    "operatingleasecostandsubleaseincome": 305000,
    "financeleaserightofuseassetamortization": 9000,
    "financeleaseinterestexpense": 2000,
    "financeleasecost": 11000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 143000,
    "lesseeoperatingleaseliabilitypaymentsdue": 143000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4000,
    "operatingleaseliability": 139000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 8000,
    "financeleaseliabilitypaymentsdue": 8000,
    "financeleaseliability": 8000,
    "gainlossfromminorityinterestinvestment": 33000000,
    "preferredstocksharesauthorized": 10000000,
    "ownershipinterestpercentageofvotingrightsofstock": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 27967,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 751633,
    "allocatedsharebasedcompensationexpense": 1152000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 824150,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.76,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 1700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisedintrinsicvalue": 10000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P3Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.85,
    "classofwarrantorrightwarrantsexpirationmonthandyear": "2024-11",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.005,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2837739,
    "stockissuedduringperiodsharesstockoptionsexercised": 8518,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 101010,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 1577255,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2837739,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.18,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.79,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.96,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 5.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodweightedaverageremainingcontractualterm": "P6Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 347000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedaggregateintrinsicvalue": 205000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 347000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 581000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 103133,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 67500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 3.85,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -22197000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -2442000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -24639000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5174000,
    "incometaxreconciliationstateandlocalincometaxes": -2293000,
    "incometaxreconciliationforeignincometaxratedifferential": 51000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 8231000,
    "incometaxreconciliationtaxcreditsresearch": 303000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 71000,
    "incometaxreconciliationchangeinfairvalueofwarrants": -2444000,
    "incometaxreconciliationchangeinfairvalueofcontingentconsideration": 911000,
    "incometaxreconciliationchangeinnetoperatingloss": -846000,
    "incometaxreconciliationotherreconcilingitems": 104000,
    "deferredtaxassetsoperatinglosscarryforwards": 41999000,
    "deferredtaxassetstaxcreditcarryforwards": 2803000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 236000,
    "deferredtaxassetspropertyplantandequipment": 63000,
    "deferredtaxassetscapitallosscarryforwards": 1115000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 337000,
    "deferredtaxassetsleaseliability": 41000,
    "deferredtaxassetstaxcreditcarryforwardsother": 129000,
    "deferredtaxassetsgross": 46723000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 4080000,
    "deferredtaxliabilitiesrightofuseassets": 39000,
    "deferredincometaxliabilities": 4119000,
    "deferredtaxassetsnet": 42604000,
    "deferredtaxassetsvaluationallowance": 42604000,
    "valuationallowancedeferredtaxassetchangeinamount": 8200000,
    "operatinglosscarryforwards": 500000,
    "taxcreditcarryforwardamount": 1100000,
    "operatinglosscarryforwardscarriedforwardindefinitely": 57400000,
    "unrecognizedassetsandliabilitiesrelatedtouncertaintaxpositions": 1300000,
    "unrecognizedtaxbenefitsoffsetbyvaluationallowance": 1300000,
    "unrecognizedtaxbenefits": 1323000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 4000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 216000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4050926
  }
]